Treatment patterns of gemcitabine-based chemotherapy in patients with de novo and recurrent advanced biliary tract cancer.

被引：0
|
作者：
Dayyani, Farshid
Stirnadel-Farrant, Heide A.
Hu, Jenny
Lin, Yian
Kebede, Nehemiah
Valerio, Stephen J.
Ahn, Daniel H.
机构：
[1] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Orange, CA USA
[2] AstraZeneca, Cambridge, England
[3] AstraZeneca, Gaithersburg, MD USA
[4] AstraZeneca, South San Francisco, CA USA
[5] Mayo Clin, Div Med Oncol, Phoenix, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
281-318-6655; 130-544; 283-237-2581-144; 281-487; 261-566-148; 6; 3; 2; 1614; 3590; 176; 239; 54; 2018; 92; 1;
D O I：
10.1200/JCO.2024.42.3_suppl.454
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：454 / 454
页数：1
相关论文
共 50 条
  • [41] Benefit of second-line chemotherapy for advanced biliary tract cancer.
    Moik, Florian
    Riedl, Jakob M.
    Winder, Thomas
    Bezan, Angelika
    Rossmann, Christopher
    Szkandera, Joanna
    Kasparek, Anne-Katrin
    Schaberl-Moser, Renate
    Pichler, Martin
    Stoger, Herbert
    Stotz, Michael
    Gerger, Armin
    Posch, Florian
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Retrospective analysis of systemic chemotherapy for unresectable advanced biliary tract cancer.
    Ishii, H
    Furuse, J
    Okusaka, T
    Yamao, K
    Funakoshi, A
    Ohkawa, S
    Boku, N
    Tanaka, K
    Nagase, M
    Saisho, H
    Sato, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 347S - 347S
  • [43] Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
    Fiteni, Frederic
    Nguyen, Thierry
    Vernerey, Dewi
    Paillard, Marie-Justine
    Kim, Stefano
    Demarchi, Martin
    Fein, Francine
    Borg, Christophe
    Bonnetain, Franck
    Pivot, Xavier
    CANCER MEDICINE, 2014, 3 (06): : 1502 - 1511
  • [44] Experience of Gemcitabine plus Oxaliplatin Chemotherapy in Patients with Advanced Biliary Tract Carcinoma
    Hollebecque, Antoine
    Bouche, Olivier
    Romano, Olivier
    Scaglia, Elodie
    Cattan, Stephane
    Zerbib, Philippe
    Heurgue, Alexandra
    Lagarde, Stephanie
    Mariette, Christophe
    Triboulet, Jean-Pierre
    Pruvot, Francois-Rene
    Hebbar, Mohamed
    CHEMOTHERAPY, 2010, 56 (03) : 234 - 238
  • [45] Gemcitabine-based induction chemotherapy and concurrent with radiation in advanced head and neck cancer
    El Deen, Doaa Ali Sharaf
    Toson, Eman Abd Elkareem
    El Morsy, Shawky Mahmoud
    MEDICAL ONCOLOGY, 2012, 29 (05) : 3367 - 3373
  • [46] Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer
    Marechal, Raphael
    Demols, Anne
    Gay, France
    de Maertelaer, Viviane
    Arvanitaki, Marianna
    Hendlisz, Alain
    Van Laethem, Jean-Luc
    PANCREAS, 2008, 36 (03) : E16 - E21
  • [47] Gemcitabine and S-1 Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer: A Retrospective Study
    Mita, Kazuhito
    Ito, Hideto
    Fukumoto, Masato
    Murabayashi, Ryo
    Nabetani, Masashi
    Koizumi, Kazuya
    Hayashi, Takashi
    CASE REPORTS IN ONCOLOGY, 2010, 3 (03): : 498 - 504
  • [48] Second-line chemotherapy in patients with biliary tract cancer.
    Brandi, G.
    Di Girolamo, S.
    de Rosa, F.
    Corbelli, J.
    Agostini, V.
    Garajova, I.
    Longobardi, C.
    Paragona, M.
    Ercolani, G.
    Pinna, A. D.
    Biasco, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [49] Efficacy and Safety of Gemcitabine Monotherapy for Patients with Advanced Biliary Tract Cancer
    Yokoyama, Tadashi
    Yoshida, Hiroshi
    Makino, Hiroshi
    Maruyama, Hiroshi
    Suzuki, Seiji
    Matsutani, Takeshi
    Matsushita, Akira
    Hirakata, Atsushi
    Sasajima, Koji
    Uchida, Eiji
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2012, 79 (03) : 204 - 212
  • [50] Toripalimab combined with gemcitabine and S-1 in the first-line treatment of advanced biliary tract cancer.
    Li, Wei
    Wang, Yueqi
    Yu, Yiyi
    Li, Qian
    Wang, Yan
    Zhang, Chenlu
    Xu, Xiaojing
    Guo, Xi
    Cui, Yuehong
    Hao, Qing
    Huang, Lujia
    Liu, Houbao
    Liu, Tianshu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345